Thus, TFEB is most likely not involved in the regulation of the ErbB2-induced, invasion-promoting lysosomal alterations in breast cancer cells, since ErbB2 activation leads to the activation of the mTOR and MAPK-ERK signaling pathways55. The gene discussed is MTOR; the disease is breast carcinoma.